PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's ...
Robert W. Baird analyst Joel Beatty has maintained their bullish stance on PTCT stock, giving a Buy rating on September 16. Joel Beatty has ...
PTC partners with AWS to accelerate product design with Onshape, making it faster and easier for designers to create ...
PTC Therapeutics, Inc. (PTCT) announced Thursday that the FDA has granted Fast Track designation to the PTC518 program for the ...
PTC Therapeutics' treatment for Huntington's disease has received a fast track designation from U.S. health regulators. The biopharmaceutical company said Thursday that the Food and Drug ...
PTC Therapeutics announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising ...
Former Delhi Chief Minister Arvind Kejriwal slammed the BJP on Thursday, speaking in the Delhi Legislative Assembly for the first time since his resignation.
Lone Pine Capital's 13F portfolio value decreased to $12.33B with holdings reduced to 24. Check out the portfolio's new ...
Potential Tropical Cyclone 9 was fighting some shear in the western Caribbean that was causing it to struggle to get ...
Potential Tropical Cyclone 9 has formed in the Caribbean, and is forecast to continue organizing into a tropical storm and ...
PTC Therapeutics, Inc. (PTCT) stock saw a modest uptick, ending the day at $36.64 which represents a slight increase of $0.48 or 1.33% from the prior close of $36.16. The stock opened at $36.2 and ...